Preventive effect of Boiogito on metabolic disorders in the TSOD mouse, a model of spontaneous obese type II diabetes mellitus

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Aburada, Masaki ^a   Shimada, Tsutomu ^a   Akase, Tomoko ^a,b   Kosugi, Mitsutaka ^c,d  

^a MUSASHINO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Graduate School of Natural Science and Technology   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; BOIOGITO; CHINESE DRUG; CHOLESTEROL; GLUCOSE; INSULIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTRAGALUS MONGKOHCUS; ATRACTYLODES LANCEA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; GLYCYRRKIZA URALENSIS; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LIPID METABOLISM; LOW DRUG DOSE; MALE; MEDICINAL PLANT; METABOLIC DISORDER; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SINOMENIUM ACUTUM; SPONTANEOUS OBESE TYPE II DIABETTES MELLITUS; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ZIBGIBER OJFICINALE; ZIZYPHUSJUJUBE;

EID: 80052708655     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nep012     Document Type: Article

References (23)

1. Matsuzawa Y., The metabolic syndrome and adipocytokines FEBS Letters 2006 580 12 2917 2921 (Pubitemid 43729162)
2. Reaven G. M., The metabolic syndrome: is this diagnosis necessary? American Journal of Clinical Nutrition 2006 83 6 1237 1247 (Pubitemid 44713049)
3. National Health and Nutrition Examination Survey 2004 by the Ministry of Health, Labour and Welfare, May 2007, http://www.mhlw.go.jp/
4. Mitani K., Metabolic syndrome and Kampo therapy Kampo the Newest Therapy 2005 14 43 47
5. Tsunakawa M., Shimada T., Suzuki W., Preventive effects of Daisaikoto on metabolic disorders in spontaneous obese type II diabetes mice Journal of Traditional Chinese Medicine 2006 23 216 223
6. Shimada T., Kudo T., Akase T., Aburada M., Preventive effects of bofutsushosan on obesity and various metabolic disorders Biological and Pharmaceutical Bulletin 2008 31 7 1362 1367 (Pubitemid 351930647)
7. Suzuki W., Iizuka S., Tabuchi M., Funo S., Yanagisawa T., Kimura M., Sato T., Endo T., Kawamura H., A new mouse model of spontaneous diabetes derived from ddY strain Experimental Animals 1999 48 3 181 189 (Pubitemid 129558684)
8. Iizuka S., Suzuki W., Tabuchi M., Nagata M., Imamura S., Kobayashi Y., Kanitani M., Yanagisawa T., Kase Y., Takeda S., Aburada M., Takahashi K. W., Diabetic complications in a new animal model (TSOD mouse) of spontaneous NIDDM with obesity Experimental Animals 2005 54 1 71 83 (Pubitemid 41349876)
9. Takahashi A., Tabuchi M., Suzuki W., Insulin resistance and low sympathetic nerve activity in the Tsumura Suzuki obese diabetic mouse: a new model of spontaneous type 2 diabetes mellitus and obesity Metabolism 2006 55 1664 9 (Pubitemid 44827134)
10. Hirayama I., Yi Z., Izumi S., Arai I., Suzuki W., Nagamachi Y., Kuwano H., Takeuchi T., Izumi T., Genetic analysis of obese diabetes in the TSOD mouse Diabetes 1999 48 5 1183 1191 (Pubitemid 29226369)
11. Mizutani S., Gomi H., Hirayama I., Izumi T., Chromosome 2 locus Nidd5 has a potent effect on adiposity in the TSOD mouse Mammalian Genome 2006 17 5 375 384 (Pubitemid 44011963)
12. Suzuki W., Iizuka S., Hiruta M, General behavior, motion and sensory role in NIDDM model TSOD mice Diabetes Frontier 1999 10 603 604. (in Japanese)
13. Edwards L. A., Bugaresti J. M., Buchholz A. C., Visceral adipose tissue and the ratio of visceral to subcutaneous adipose tissue are greater in adults with than in those without spinal cord injury, despite matching waist circumferences American Journal of Clinical Nutrition 2008 87 600 607 (Pubitemid 351364540)
14. Toshihiko H., The Lesson for Kampo Therapy 1995 27 Tokyo, Japan Kanehara Co., Ltd 130
15. Tsumura A., KAMPO: How the Japanese Updated Traditional Herbal Medicine 1991 Tokyo, Japan Japan Publications
16. Tsutsumi T., Kobayashi S., Liu Y. Y., Kontani H., Anti-hyperglycemic effect of fangchinoline isolated from Stephania tetrandra Radix in streptozotocin-diabetic mice Biological and Pharmaceutical Bulletin 2003 26 3 313 317 (Pubitemid 39663616)
17. Yuan Y. L., Shinjiro K., Taiki T Hitoshi K., Combined effects of Stephania Radix and Astragali Radix in antihyperglycemic action of Boi-ogi-to (fang-ji-huang-qi-tang) in streptozotocin-induced diabetic mice Journal of Traditional Chinese Medicine 2000 17 253 260
18. Yamakawa J.-I., Moriya J., Takahashi T., Ishige A., Motoo Y., Yoshizaki F., Kanda T., A kampo medicine, boi-ogi-to, inhibits obesity in ovariectomized rats Evidence-Based Complementary and Alternative Medicine 2010 7 1 87 95
19. Morishima A., Experience of Kampo therapy against obesity Journal of Parenteral and Enteral Nutrition 1985 7 472 473
20. Han L.-K., Gong X.-J., Kawano S., Saito M., Kimura Y., Okuda H., Antiobesity actions of Zingiber officinale Roscoe Yakugaku Zasshi 2005 125 2 213 217 (Pubitemid 40628411)
21. Bhandari U., Sharma J. N., Zafar R., The protective action of ethanolic ginger (Zingiber officinale) extract in cholesterol fed rabbits Journal of Ethnopharmacology 1998 61 2 167 171 (Pubitemid 28297907)
22. Tanabe M., Chen Y.-D., Saito K., Kano Y., Cholesterol biosynthesis inhibitory component from Zingiber officinale Roscoe Chemical and Pharmaceutical Bulletin 1993 41 4 710 713 (Pubitemid 23166144)
23. Takii H., Kometani T., Nishimura T., Nakae T., Okada S., Fushiki T., Antidiabetic effect of glycyrrhizin in genetically diabetic KK-Ay mice Biological and Pharmaceutical Bulletin 2001 24 5 484 487 (Pubitemid 32499471)